Archive — US — techcrunch
Musely secures $360M from General Catalyst without giving up equity
Musely, a telemedicine platform for skin and menopause care, secured $360M from General Catalyst’s Customer Value Fund without diluting equity. Founded in 2014, the cash flow positive company has grown its revenue by 50% yearly and serves over 1.2M patients. The non-dilutive capital will enhance customer acquisition efforts, reflecting a trend in alternative funding models in the DTC sector.
Key points
- Musely specializes in compounded treatments for skin, hair, and menopause.
- Raised $360M non-dilutive capital from General Catalyst’s CVF, avoiding equity dilution.
- Company has been cash flow positive for years with 50% average revenue growth.
- Jia was initially hesitant but found CVF's terms more favorable than loans or equity rounds.
- Funding will support customer acquisition in a costly DTC market with high capital burn.
Why it matters
- Reflects a growing trend of non-dilutive funding models in the startup ecosystem.
- Connections with other DTC brands facing similar customer acquisition challenges.
- Highlighting innovations in telemedicine amidst a rise in digital health solutions due to the pandemic.
Musely's successful funding showcases a trend towards recognizing the value of alternative capital structures in the DTC market, emphasizing capital efficiency and sustainable growth strategies.